Reyobiq (rhenium Re186 obisbemeda) - Plus Therap
Phase 1 Study of WBRT or PCSI With REYOBIQ for Leptomeningeal Metastases (clinicaltrials.gov) - Jun 30, 2026 - P1 | N=29 | Not yet recruiting | Sponsor: NYU Langone Health 
New P1 trial • Oncology • CTCs
http://clinicaltrials.gov/ct2/show/NCT07674693
 
Jun 30, 2026
 
Prev Next